Darren Reyes Email
Research Associate . Vironexis Biotherapeutics
,
LocationPrimary Email
How to contact Darren Reyes
Join and see Darren's contact info for free!Current Roles
Employees:
10Revenue:
$1.6MAbout
Vironexis is focused on transforming the future of cancer treatment by pioneering AAV-delivered T-cell immunotherapy. Our TransJoin™ AAV Gene Therapy Platform enables the creation of off-the-shelf, single-dose gene therapies designed to overcome the key challenges and shortcomings of current immunotherapies, including CAR-T. Our current pipeline includes more than ten product candidates for blood-based cancers, solid tumor metastasis prevention, and a cancer vaccine. Our lead program, VNX-101, for the treatment of CD19+ acute lymphoblastic leukemia, is anticipated to begin clinical trials in the fourth quarter of 2024.Vironexis Biotherapeutics Address
null, null
United States